IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellicum Pharm., Inc. 5

CUSIP: 9EDW5GYA8 | 1 institutional holders

Quarters

Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2019

Knott David M100
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Knott David M
100$10.0%N/AN/ASyosset, NY2019-11-12